Asian American doctors largely absent from leadership roles; Democrats already want to expand Medicare’s drug price negotiation

"Working hard and having all kinds of accomplishments may get you ... a faculty appointment, but it doesn't get you into the C-suite."

July 26, 2023 Check out STAT+

Sponsored By

Sylvia Jarrus for STAT Asian American doctors, overrepresented in medicine, are largely left out of leadership The lack of Asian American doctors in top jobs is invisible in many analyses of leadership, which lump them with their white colleagues. By Usha Lee McFarling Q&A with CDC Director Mandy Cohen: On communication, trust, and getting things done In a Q&A with STAT, Cohen spoke about rebuilding trust with the agency and what she's learned from previous directors. By Helen Branswell STAT+ | Democrats already want to expand Medicare drug price negotiation Democrats put out a blueprint for how they hope to expand on a Medicare drug pricing law if they take back control of the House in 2024. By Rachel Cohrs and John Wilkerson Opinion: Why physicians should let patients call them by their first names Stephanie W. Edmonds and Ginny L. Ryan discuss their viral First Opinion piece on the honorific "doctor." By Torie Bosch STAT+ | Democrats decry a new health package as too easy on private equity There's a rift between Democrats and Republicans over whether to shed light on private equity investors in health care companies. By Rachel Cohrs STAT+ | Congress's PBM reforms won't end America's drug pricing woes. Here's what they would do Lawmakers are trying to rein in pharmacy middlemen — but none of their ideas will stop the dynamic that has incentivized higher drug prices. By Rachel Cohrs Photo illustration: Casey Shenery for STAT A psychologist's lifetime of challenging assumptions while living with paralysis Psychologist Nikki Saltzburg on navigating the healthcare system as a disabled person and how she's had to advocate for herself. By Simar Bajaj STAT+ | FDA inspection underscores problem at major U.S. compounder behind hospital drug recalls Over the past decade, several facilities run by Central Admixture Pharmacy Services have drawn attention from the FDA. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser